Analyst Ratings For Allergy Therapeutics plc (LON:AGY)
Today, Numis Securities Ltd reiterated its Buy rating on Allergy Therapeutics plc (LON:AGY) with a price target of GBX 45.
There are 4 buy ratings on the stock.
The current consensus rating on Allergy Therapeutics plc (LON:AGY) is Buy (Score: 3.00) with a consensus target price of GBX 51 per share, a potential .
Some recent analyst ratings include
- 7/18/2017-Numis Securities Ltd Reiterated Rating of Buy.
- 4/20/2017-Panmure Gordon Reiterated Rating of Buy.
- 4/4/2017-Stifel Nicolaus Reiterated Rating of Buy.
Recent Trading Activity for Allergy Therapeutics plc (LON:AGY)
Shares of Allergy Therapeutics plc closed the previous trading session at 29.75 up +4.00 15.53% with 0 shares trading hands.